Cancer Research Center.
Cancer Research Center.

Cancer Research Center.



   recombinant cd40
   Epitope Mapping
   nextgen sequencing
   organic synthesis
   HUman tissue

  Letztes Feedback
   3.10.12 09:15
    lig6oq fnzdmjowthnc, [u
   3.10.12 15:15
    IUCqym    4.06.13 05:30
Click For Info
   10.08.13 20:50
       13.08.13 06:56
   20.12.13 08:52
    Ich wollte einfach einen

Gratis bloggen bei

Increased urinary CCL2: Cr ratio in 6 months later the renal allograft loss.

Background: Early non-invasive markers, identification of risk patients renal allograft loss work stratified patients may more monitoring or treatment. Is a CCR2 CCL2 chemokine receptor protein, this is a chemoattractant to monocytes/macrophages, T cells and natural killer cells. We've demonstrates in a multicenter cohort, urine CCL2 in 6 months is an independent predictor of IFTA in 24 months. The goal of this study was to determine the early can predict urine CCL2 graft loss in an independent patient population. Methods: A prospective observational cohort study on the adult kidney transplant Manitoba program (n = 231) from 1997 to 2008. Six months of urine CCL2 measured the ELISA, remove urine creatinine, and long-term transplantation results. Results: Urine CCL2: Cr in 6 months significant related death review graft loss (odds ratio, 2.42; 95% CI, 1.54 to 3.82, P < 0.0001). In multivariate analysis, urine CCL2: Cr in 6 months is still an independent predict death review graft loss (odds ratio, 2.20; 95% CI, 1.18 to 4.10, P = 0.01) after the adjustment before transplantation/DE novo specific antibodies and delayed graft function. Early transplantation (6 months or less) multivariate model the CCL2, the recipient's age, and delayed graft function recovery produced a 0.87 AUC predict death review graft loss. A cut-off value of urine CCL2: Cr 34.8 ng/and a strong positive predictive value is 0.96. Conclusion: The study confirmed in a separate prospective cohort, early urine CCL2 in 6 months is a non-invasive, independent indicate late renal allograft loss.
11.12.12 13:41
Letzte Einträge: Iatrogenic false aneurysm treatment use ultrasound-guided thrombin injection in during the five years, Enhancement effect function of T cell CD8 from healthy controls and patients with HIV infection is through the activation of thrombin receptor 1 protease activity., Thrombin cracking fragment in malignant osteopontin is overexpressed glial tumors, and provides a molecular niche and survival advantage, Macrophages, epithelial cells of the CCL2 help rhinovirus induced high reactivity and inflammation in a mouse model of air allergic disease., Differential regulation of CD4 + T cell adhesion to the brain microvascular endothelial & # 946; The CCL2 and CCL3 chemokines


bisher 0 Kommentar(e)     TrackBack-URL

E-Mail bei weiteren Kommentaren
Informationen speichern (Cookie)

 Smileys einfügen

Verantwortlich für die Inhalte ist der Autor. Dein kostenloses Blog bei! Datenschutzerklärung